NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update - March 6, 2024

Indian Equity Benchmarks are expected to open lower, tracking losses in GIFT Nifty, which is currently trading at 24,605.

Key Statistics

  • Sensex: down 1,122.66 points or 1.40% at 79,116.19
  • Nifty: down 385.20 points or 1.55% at 24,480.50

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Global Markets

  • Asian Equities: fell on Friday, with markets on track for their steepest weekly loss in six years due to the Middle East conflict and Iranian strikes.
  • US Equities: closed down on Thursday, with the Dow Jones Industrial Average falling 784.67 points or 1.61% to 47,954.74.
  • S&P 500: lost 0.56% to 6,830.71.
  • Nasdaq Composite: closed down 0.26% to 22,748.99.

Currency and Commodities

  • US Dollar: held broadly steady in early Asian trade on Friday.
  • WTI Crude: moving lower after the US Treasury Secretary announced a 30-day waiver to allow Indian refiners to buy Russian oil.
  • Gold: on track for the first weekly loss in more than a month, pressured by a stronger US dollar and inflationary risks.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Fund Flow Action

  • Foreign Institutional Investors (FIIs): continued selling on the fifth consecutive session, offloading equities worth Rs 3,752 crore.
  • Domestic Institutional Investors (DIIs): continued buying momentum for the seventh straight day, purchasing shares worth over Rs 5,000 crore.

Investor Takeaway

Investors should be cautious of potential market volatility due to global conflicts.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.